Article(id=1330183902800490765, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330183874530882528, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2023.04.004, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1653840000000, receivedDateStr=2022-05-30, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795070156049, onlineDateStr=2026-11-19, pubDate=1681056000000, pubDateStr=2023-04-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795070156049, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795070156049, creator=13701087609, updateTime=1795070156049, updator=13701087609, issue=Issue{id=1330183874530882528, tenantId=1146029695717560320, journalId=1319690259887390882, year='2023', volume='54', issue='4', pageStart='471', pageEnd='634', issueExtLink='null', onlineDate='null', pubDate='1681056000000', pubDateStr='2023-04-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795070149309, creator='13701087609', updateTime=1795080460960, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330227125417783583, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330183874530882528, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330227125421977888, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330183874530882528, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=496, endPage=503, ext={EN=ArticleExt(id=1330183903014400270, articleId=1330183902800490765, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Advances in Red Blood Cells as Drug Delivery Systems, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Traditional therapeutic drugs have many shortcomings, such as poor stability, low uptake efficiency, high cytotoxicity and poor targeting ability. Therefore, safe drug delivery systems are needed to prolong drug circulation and exposure in vivo. New drug delivery systems based on red blood cells have gradually become ideal platforms for drug delivery due to their good biocompatibility, low immunogenicity and long circulation time. There are various types of drug delivery systems based on red blood cells, such as red blood cell membrane-encapsulated nanoparticle drug delivery systems and genetically engineered red blood cells. In addition, the functional modification of red blood cells can significantly enhance the targeting of red blood cell-based drug delivery systems to further develop and expand their applications in the treatment of various diseases. This review introduces the delivery methods of chemical drugs and vaccines using red blood cell-based carriers, focuses on bionic nano drug delivery systems and their targeting properties to various body positions. And the research progress of genetically engineered red blood cell-based strategy in recent years is summarized.

, authors=Meiyu GUO, Lu WANG, Xiaodan QI*, authorsList=Meiyu GUO, Lu WANG, Xiaodan QI, authorCompany=null, correspAuthors=Xiaodan QI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330183903291224335, articleId=1330183902800490765, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=红细胞作为药物递送系统的研究进展, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

传统的治疗药物存在稳定性差、摄取效率低、细胞毒性大以及靶向能力差等缺点。因此需要安全的药物传递系统来延长药物在体内的循环和暴露。以红细胞为载体的新型药物递送系统凭借其良好的生物相容性、低免疫原性以及长循环时间而逐渐成为理想的药物递送平台。基于红细胞的药物递送系统包括多种类型,主要有红细胞膜包裹纳米颗粒载药系统和基因工程红细胞等。另外,对红细胞进行功能化修饰,可显著增强靶向性,进一步开发和扩大红细胞载药体系在多种疾病治疗中的应用。本研究介绍了以红细胞为载体的化学药物及疫苗的递送方法,重点讨论了仿生纳米红细胞药物递送系统及其对机体各部位的靶向性研究,并且总结了近年来基因工程红细胞策略的研究进展。

, authors=郭美瑜, 王璐, 齐晓丹*, authorsList=郭美瑜, 王璐, 齐晓丹, authorCompany=null, correspAuthors=齐晓丹, authorNote=

郭美瑜(1999—),女,硕士研究生,专业方向:药物新剂型与新技术。

, correspAuthorsNote=
齐晓丹(1975—),女,副教授,从事药物制剂新剂型、新技术的研究与开发。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=C1DZQ73Gx5NnpwpUVAGSRQ==, magXml=1pWSv9ofdCjX7Uh0rFrCLA==, pdfUrl=null, pdf=uVCy/b3Kxz4ZLoMKJaX9Zg==, pdfFileSize=1544606, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=9GA0QYn/fDmCH/gEIH66Og==, mapNumber=null, fund=null)}, authors=[Author(id=1330183903593214228, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183903672906006, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, authorId=1330183903593214228, language=EN, stringName=Meiyu GUO, firstName=Meiyu, middleName=null, lastName=GUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Pharmacy Dept., School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183903760986391, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, authorId=1330183903593214228, language=CN, stringName=郭美瑜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=河北医科大学药学院药剂教研室,河北 石家庄 050017, bio={"content":"

郭美瑜(1999—),女,硕士研究生,专业方向:药物新剂型与新技术。

"}, bioImg=null, bioContent=

郭美瑜(1999—),女,硕士研究生,专业方向:药物新剂型与新技术。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183903500939536, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, xref=null, ext=[AuthorCompanyExt(id=1330183903509328145, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, companyId=1330183903500939536, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Pharmacy Dept., School of Pharmacy, Hebei Medical University, Shijiazhuang 050017), AuthorCompanyExt(id=1330183903517716754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, companyId=1330183903500939536, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河北医科大学药学院药剂教研室,河北 石家庄 050017)])]), Author(id=1330183903849066777, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183903941341467, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, authorId=1330183903849066777, language=EN, stringName=Lu WANG, firstName=Lu, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Pharmacy Dept., School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183904021033244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, authorId=1330183903849066777, language=CN, stringName=王璐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=河北医科大学药学院药剂教研室,河北 石家庄 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183903500939536, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, xref=null, ext=[AuthorCompanyExt(id=1330183903509328145, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, companyId=1330183903500939536, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Pharmacy Dept., School of Pharmacy, Hebei Medical University, Shijiazhuang 050017), AuthorCompanyExt(id=1330183903517716754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, companyId=1330183903500939536, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河北医科大学药学院药剂教研室,河北 石家庄 050017)])]), Author(id=1330183904096530718, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=dzihwt@sina.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330183904192999712, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, authorId=1330183904096530718, language=EN, stringName=Xiaodan QI, firstName=Xiaodan, middleName=null, lastName=QI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Pharmacy Dept., School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183904281080097, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, authorId=1330183904096530718, language=CN, stringName=齐晓丹, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=河北医科大学药学院药剂教研室,河北 石家庄 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183903500939536, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, xref=null, ext=[AuthorCompanyExt(id=1330183903509328145, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, companyId=1330183903500939536, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Pharmacy Dept., School of Pharmacy, Hebei Medical University, Shijiazhuang 050017), AuthorCompanyExt(id=1330183903517716754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, companyId=1330183903500939536, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河北医科大学药学院药剂教研室,河北 石家庄 050017)])])], keywords=[Keyword(id=1330183904398520610, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, language=EN, orderNo=1, keyword=targeting), Keyword(id=1330183904469823779, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, language=EN, orderNo=2, keyword=genetically engineered red blood cell), Keyword(id=1330183904545321252, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, language=EN, orderNo=3, keyword=drug delivery system), Keyword(id=1330183904612430117, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, language=EN, orderNo=4, keyword=bionic nano drug delivery system), Keyword(id=1330183904687927590, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, language=CN, orderNo=1, keyword=靶向性), Keyword(id=1330183904776007975, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, language=CN, orderNo=2, keyword=基因工程红细胞), Keyword(id=1330183904910225704, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, language=CN, orderNo=3, keyword=药物递送系统), Keyword(id=1330183905019277609, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, language=CN, orderNo=4, keyword=仿生纳米药物递送系统)], refs=[Reference(id=1330183905119940906, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=DENG X, ZHAO J, LIU K, et al. Stealth PEGylated chitosan polyelectrolyte complex nanoparticles as drug delivery carrier [J]. J Biomater Sci Polym Ed, 2021,32(11): 1387-1405., articleTitle=null, refAbstract=null), Reference(id=1330183906764108075, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=ALMEIDA B, NAG O K, ROGERS K E, et al. Recent progress in bioconjugation strategies for liposome-mediated drug delivery [J]. Molecules, 2020, 25(23): 5672., articleTitle=null, refAbstract=null), Reference(id=1330183906852188460, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=DANIYAL M, JIAN Y Q, XIAO F, et al. Development of a nanodrug-delivery system, camouflaged by erythrocytes membrane for the chemo/phototherapy of cancer [J]. Nanomedicine, 2020, 15(7): 691-709., articleTitle=null, refAbstract=null), Reference(id=1330183906957046061, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=XIAO Y, GU Y, QIN L, et al. Injectable thermosensitive hydrogel-based drug delivery system for local cancer therapy[J]. Colloids Surf B, 2021, 200: 111581., articleTitle=null, refAbstract=null), Reference(id=1330183907032543534, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=HARISA G I, IBRAHIM M F, ALANAZI F, et al. Engineering erythrocytes as a novel carrier for the targeted delivery of the anticancer drug paclitaxel [J]. Saudi Pharm J, 2014, 22(3): 223-230., articleTitle=null, refAbstract=null), Reference(id=1330183907175149872, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=MENG W, HE C, HAO Y, et al. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source [J]. Drug Deliv, 2020, 27(1): 585-598., articleTitle=null, refAbstract=null), Reference(id=1330183907254841649, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=SHARMA R, ZHAO H, AL-SALEEM F H, et al. Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor[J]. Mol Immunol, 2014, 57(2): 247-254., articleTitle=null, refAbstract=null), Reference(id=1330183907355504946, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=FANG R H, JIANG Y, FANG J C, et al. Cell membrane-derived nanomaterials for biomedical applications [J]. Biomaterials, 2017, 128: 69-83., articleTitle=null, refAbstract=null), Reference(id=1330183907443585331, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG C, HUANG J, ZHANG Y, et al. Construction and evaluation of red blood cells-based drug delivery system for chemo-photothermal therapy [J]. Colloids Surf B, 2021,204: 111789., articleTitle=null, refAbstract=null), Reference(id=1330183907523277108, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG S Q, FU Q, ZHANG Y J, et al. Surface loading of nanoparticles on engineered or natural erythrocytes for prolonged circulation time: strategies and applications [J]. Acta Pharmacol Sin, 2021, 42(7): 1040-1054., articleTitle=null, refAbstract=null), Reference(id=1330183907598774581, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG Y, CHEN X, HE D, et al. Surface-modified nanoerythrocyte loading DOX for targeted liver cancer chemotherapy [J]. Mol Pharm, 2018, 15(12): 5728-5740., articleTitle=null, refAbstract=null), Reference(id=1330183907703632182, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=ZELEPUKIN, YAREMENKO A V, SHIPUNOVA V O, et al. Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth [J]. Nanoscale,2019, 11(4): 1636-1646., articleTitle=null, refAbstract=null), Reference(id=1330183907808489783, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG F, ZONG R, CHEN G. Erythrocyte-enabled immunomodulation for vaccine delivery [J]. J Control Release, 2022, 341: 314-328., articleTitle=null, refAbstract=null), Reference(id=1330183907896570168, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=RANI N, ALZUBAIDI Z M, AZHARI H, et al. Novel engineering: biomimicking erythrocyte as a revolutionary platform for drugs and vaccines delivery [J]. Eur J Pharm,2021, 900: 174009., articleTitle=null, refAbstract=null), Reference(id=1330183907976261945, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=HE H, YE J, WANG Y, et al. Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application [J]. J Control Release, 2014,176: 123-132., articleTitle=null, refAbstract=null), Reference(id=1330183908055953722, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG X, QIU M, GUO P, et al. Autologous red blood cell delivery of betamethasone phosphate sodium for long anti-inflammation [J]. Pharmaceutics, 2018, 10(4): 286., articleTitle=null, refAbstract=null), Reference(id=1330183908148228411, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=CHENG Z, LIU S, WU X, et al. Autologous erythrocytes delivery of berberine hydrochloride with long-acting effect for hypolipidemia treatment [J]. Drug Delive, 2020, 27(1):283-291., articleTitle=null, refAbstract=null), Reference(id=1330183908227920188, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=XU E, WU X, ZHANG X, et al. Study on the protection of dextran on erythrocytes during drug loading [J]. Colloids Surf B, 2020, 189: 110882., articleTitle=null, refAbstract=null), Reference(id=1330183908311806269, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN Z, WU S, CHEN P, et al. Critical features for mesoporous silica nanoparticles encapsulated into erythrocytes [J]. ACS Appl Mater Inter, 2019, 11(5): 4790-4798., articleTitle=null, refAbstract=null), Reference(id=1330183908387303742, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=ZAITSEV S, SPITZER D, MURCIANO J, et al. Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis [J]. J Pharmacol Exp Ther, 2010, 332(3): 1022-1031., articleTitle=null, refAbstract=null), Reference(id=1330183908466995519, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=LORENTZ K M, KONTOS S, DIACERI G, et al. Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase [J]. Sci Adv, 2015, 1(6):e1500112., articleTitle=null, refAbstract=null), Reference(id=1330183908550881600, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=陈萌,刘梦阳,张琦,等.红细胞膜药物递送系统的研究进展与反思[J].沈阳药科大学学报,2020,37(6):556-563., articleTitle=null, refAbstract=null), Reference(id=1330183908672516417, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=YEW N S, DUFOUR E, PRZYBYLSKA M, et al. Erythrocytes encapsulated with phenylalanine hydroxylase exhibit improved pharmacokinetics and lowered plasma phenylalanine levels in normal mice [J]. Mol Genet Metab,2013, 109(4): 339-344., articleTitle=null, refAbstract=null), Reference(id=1330183908781568322, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=冯之资,沈诗洋,莫然.基于红细胞的仿生载体用于光热剂递送和肿瘤光热治疗的研究进展[J].中国医药工业杂志,2022,53(1):28-36., articleTitle=null, refAbstract=null), Reference(id=1330183908857065795, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=PAN D C, MYERSON J W, BRENNER J S, et al. Nanoparticle properties modulate their attachment and effect on carrier red blood cells [J]. Sci Rep UK, 2018, 8(1):1615., articleTitle=null, refAbstract=null), Reference(id=1330183908936757572, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=LI H, JIN K, LUO M, et al. Size dependency of circulation and biodistribution of biomimetic nanoparticles: red blood cell membrane-coated nanoparticles [J]. Cells Basel, 2019,8(8): 881., articleTitle=null, refAbstract=null), Reference(id=1330183909037420869, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU J, ZHANG D, FANG G, et al. Erythrocyte membrane bioinspired near-infrared persistent luminescence nanocarriers for in vivo long-circulating bioimaging and drug delivery [J]. Biomaterials, 2018, 165: 39-47., articleTitle=null, refAbstract=null), Reference(id=1330183909138084166, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=UKIDVE A, ZHAO Z, FEHNEL A, et al. Erythrocyte-driven immunization via biomimicry of their natural antigen-presenting function [J]. Proc Natl Acad Sci USA, 2020,117(30): 17727-17736., articleTitle=null, refAbstract=null), Reference(id=1330183909217775943, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=HAN X, SHEN S, FAN Q, et al. Red blood cell-derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy [J]. Sci Adv, 2019, 5(10): w6870., articleTitle=null, refAbstract=null), Reference(id=1330183909293273416, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=BANZ A, CREMEL M, REMBERT A, et al. In situ targeting of dendritic cells by antigen-loaded red blood cells:a novel approach to cancer immunotherapy [J]. Vaccine,2010, 28(17): 2965-2972., articleTitle=null, refAbstract=null), Reference(id=1330183909372965193, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=XIA Q, ZHANG Y, LI Z, et al. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application [J]. Acta Pharm Sin B, 2019, 9(4):675-689., articleTitle=null, refAbstract=null), Reference(id=1330183909465239882, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG M, YAN W, CHU M, et al. Erythrocyte membrane-wrapped magnetic nanotherapeutic agents for reduction and removal of blood Cr(Ⅳ) [J]. ACS Appl Mater Interfaces,2020, 12(25): 28014-28023., articleTitle=null, refAbstract=null), Reference(id=1330183909536543051, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=CHU J, SHAO C, HA S, et al. One-pot peptide cyclisation and surface modification of photosensitiser-loaded red blood cells for targeted photodynamic therapy [J]. Biomater Sci,2021, 9(23): 7832-7837., articleTitle=null, refAbstract=null), Reference(id=1330183909624623436, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=FANG R H, HU C J, CHEN K N H, et al. Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles [J]. Nanoscale, 2013, 5(19): 8884., articleTitle=null, refAbstract=null), Reference(id=1330183909708509517, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=JIANG Q, LIU Y, GUO R, et al. Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors [J]. Biomaterials,2019, 192: 292-308., articleTitle=null, refAbstract=null), Reference(id=1330183911327510862, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN Z, WANG W, LI Y, et al. Folic acid-modified erythrocyte membrane loading dual drug for targeted and chemo-photothermal synergistic cancer therapy [J]. Mol Pharm, 2021, 18(1): 386-402., articleTitle=null, refAbstract=null), Reference(id=1330183911440757071, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=HUANG J, LAI W, WANG Q, et al. Effective triple-negative breast cancer targeted treatment using iRGD-modified RBC membrane-camouflaged nanoparticles [J]. Int J Nanomed, 2021, 16: 7497-7515., articleTitle=null, refAbstract=null), Reference(id=1330183911524643152, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=GUO Y, WANG D, SONG Q, et al. Erythrocyte membrane-enveloped polymeric nanoparticles as nanovaccine for induction of antitumor immunity against melanoma [J]. ACS Nano, 2015, 9(7): 6918-6933., articleTitle=null, refAbstract=null), Reference(id=1330183911604334929, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=CHAI Z, RAN D, LU L, et al. Ligand-modified cell membrane enables the targeted delivery of drug nanocrystals to glioma [J]. ACS Nano, 2019, 13(5): 5591-5601., articleTitle=null, refAbstract=null), Reference(id=1330183911692415314, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=DING Y, LV B, ZHENG J, et al. RBC-hitchhiking chitosan nanoparticles loading methylprednisolone for lung-targeting delivery [J]. J Control Release, 2022, 341: 702-715., articleTitle=null, refAbstract=null), Reference(id=1330183911801467219, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=ANSELMO A C, KUMAR S, GUPTA V, et al. Exploiting shape, cellular-hitchhiking and antibodies to target nanoparticles to lung endothelium: synergy between physical, chemical and biological approaches [J]. Biomaterials,2015, 68: 1-8., articleTitle=null, refAbstract=null), Reference(id=1330183911868576084, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHENG J, LU C, DING Y, et al. Red blood cell-hitchhiking mediated pulmonary delivery of ivermectin: effects of nanoparticle properties [J]. Int J Pharm, 2022, 619:121719., articleTitle=null, refAbstract=null), Reference(id=1330183911939879253, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=GUO J, AGOLA J O, SERDA R, et al. Biomimetic rebuilding of multifunctional red blood cells: modular design using functional components [J]. ACS Nano, 2020, 14(7):7847-7859., articleTitle=null, refAbstract=null), Reference(id=1330183912015376726, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=WU P, JIANG X, YIN S, et al. Biomimetic recombinant of red blood cell membranes for improved photothermal therapy[J]. J Nanobiotechnol, 2021, 19(1): 213., articleTitle=null, refAbstract=null), Reference(id=1330183912090874199, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=DEHNIAI D, WEI X, FANG R H, et al. Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization [J]. Adv Mater, 2017, 29(16): 1606209., articleTitle=null, refAbstract=null), Reference(id=1330183912170565976, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=YAO Q, YANG G, WANG H, et al. Aging erythrocyte membranes as biomimetic nanometer carriers of liver-targeting chromium poisoning treatment [J]. Drug Deliv,2021, 28(1): 1455-1465., articleTitle=null, refAbstract=null), Reference(id=1330183912267034969, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG Y, ZHANG K, QIN X, et al. Biomimetic nanotherapies: red blood cell based core-shell structured nanocomplexes for atherosclerosis management [J]. Adv Sci, 2019, 6(12): 1900172., articleTitle=null, refAbstract=null), Reference(id=1330183912359309658, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=CHAI Z, HU X, WEI X, et al. A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery[J]. J Control Release, 2017, 264: 102-111., articleTitle=null, refAbstract=null), Reference(id=1330183912434807133, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=GAO C, WANG Y, SUN J, et al. Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer’s disease mice [J]. Acta Biomater, 2020, 108: 285-299., articleTitle=null, refAbstract=null), Reference(id=1330183912522887518, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=IIU X, ZHANG L, JIANG W, et al. In vitro and in vivo evaluation of liposomes modified with polypeptides and red cell membrane as a novel drug delivery system for myocardium targeting [J]. Drug Deliv, 2020, 27(1): 599-606., articleTitle=null, refAbstract=null), Reference(id=1330183912606773599, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=BRENNER J S, PAN D C, MYERSON J W, et al. Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude [J]. Nat Commun,2018, 9(1): 2684., articleTitle=null, refAbstract=null), Reference(id=1330183912690659680, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHAO Z, UKIDVE A, KRISHNAN V, et al. Systemic tumour suppression via the preferential accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung metastases [J]. Nat Biomed Eng, 2021, 5(5): 441-454., articleTitle=null, refAbstract=null), Reference(id=1330183912774545761, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU P, OUCHARI M, XUE Y, et al. In vitro generation of red blood cells from stem cell and targeted therapy [J]. Cell Transplant, 2020, 29: 1504., articleTitle=null, refAbstract=null), Reference(id=1330183912862626146, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=BAX B E. Erythrocytes as carriers of therapeutic enzymes[J]. Pharmaceutics, 2020, 12(5): 435., articleTitle=null, refAbstract=null), Reference(id=1330183912942317923, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=MCARDEL S L, DUGAST A, HOOVER M E, et al. Anti-tumor effects of RTX-240: an engineered red blood cell expressing 4-1BB ligand and interleukin-15 [J]. Cancer Immunol, 2021, 70(9): 2701-2719., articleTitle=null, refAbstract=null), Reference(id=1330183913030398308, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=HUANG N J, PISHESHA N, MUKHERJEE J, et al. Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin [J]. Nat Commun, 2017, 8(1): 423., articleTitle=null, refAbstract=null), Reference(id=1330183913105895781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=GAO L, WANG H, NAN L, et al. Erythrocyte membrane-wrapped pH sensitive polymeric nanoparticles for non-small cell lung cancer therapy [J]. Bioconjug Chem, 2017,28(10): 2591-2598., articleTitle=null, refAbstract=null), Reference(id=1330183913189781862, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[58], rfOrder=57, authorNames=null, journalName=null, refType=null, unstructuredReference=LI N, CAI H, JIANG L, et al. Enzyme-sensitive and amphiphilic PEGylated dendrimer-paclitaxel prodrug-based nanoparticles for enhanced stability and anticancer efficacy[J]. ACS Appl Mater Interfaces, 2017, 9(8): 6865-6877., articleTitle=null, refAbstract=null), Reference(id=1330183913315610983, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[59], rfOrder=58, authorNames=null, journalName=null, refType=null, unstructuredReference=DENG X, CHEN Y, CHENG Z, et al. Rational design of a comprehensive cancer therapy platform using temperature-sensitive polymer grafted hollow gold nanospheres:simultaneous chemo/photothermal/photodynamic therapy triggered by a 650 nm laser with enhanced anti-tumor efficacy [J]. Nanoscale, 2016, 8(12): 6837-6850., articleTitle=null, refAbstract=null), Reference(id=1330183913403691368, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[60], rfOrder=59, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG L, CHEN S, PEI W, et al. Magnetically targeted erythrocyte membrane coated nanosystem for synergistic photothermal/chemotherapy of cancer [J]. J Mater Chem B,2020, 8(18): 4132-4142., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330183903500939536, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, xref=null, ext=[AuthorCompanyExt(id=1330183903509328145, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, companyId=1330183903500939536, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Pharmacy Dept., School of Pharmacy, Hebei Medical University, Shijiazhuang 050017), AuthorCompanyExt(id=1330183903517716754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, companyId=1330183903500939536, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河北医科大学药学院药剂教研室,河北 石家庄 050017)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.04.004, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2023.04.004, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2023.04.004, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2023.04.004, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1681056000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
红细胞作为药物递送系统的研究进展
郭美瑜 , 王璐 , 齐晓丹 *
中国医药工业杂志 | 综述 2023,54(4): 496-503
收起
收藏切换
中国医药工业杂志 |综述 2023 , 54 (4) : 496 -503
红细胞作为药物递送系统的研究进展
全屏
[Author(id=1330183903593214228, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183903672906006, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, authorId=1330183903593214228, language=EN, stringName=Meiyu GUO, firstName=Meiyu, middleName=null, lastName=GUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Pharmacy Dept., School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183903760986391, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, authorId=1330183903593214228, language=CN, stringName=郭美瑜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=河北医科大学药学院药剂教研室,河北 石家庄 050017, bio={"content":"

郭美瑜(1999—),女,硕士研究生,专业方向:药物新剂型与新技术。

"}, bioImg=null, bioContent=

郭美瑜(1999—),女,硕士研究生,专业方向:药物新剂型与新技术。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183903500939536, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, xref=null, ext=[AuthorCompanyExt(id=1330183903509328145, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, companyId=1330183903500939536, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Pharmacy Dept., School of Pharmacy, Hebei Medical University, Shijiazhuang 050017), AuthorCompanyExt(id=1330183903517716754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, companyId=1330183903500939536, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河北医科大学药学院药剂教研室,河北 石家庄 050017)])]), Author(id=1330183903849066777, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183903941341467, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, authorId=1330183903849066777, language=EN, stringName=Lu WANG, firstName=Lu, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Pharmacy Dept., School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183904021033244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, authorId=1330183903849066777, language=CN, stringName=王璐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=河北医科大学药学院药剂教研室,河北 石家庄 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183903500939536, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, xref=null, ext=[AuthorCompanyExt(id=1330183903509328145, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, companyId=1330183903500939536, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Pharmacy Dept., School of Pharmacy, Hebei Medical University, Shijiazhuang 050017), AuthorCompanyExt(id=1330183903517716754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, companyId=1330183903500939536, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河北医科大学药学院药剂教研室,河北 石家庄 050017)])]), Author(id=1330183904096530718, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=dzihwt@sina.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330183904192999712, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, authorId=1330183904096530718, language=EN, stringName=Xiaodan QI, firstName=Xiaodan, middleName=null, lastName=QI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Pharmacy Dept., School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183904281080097, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, authorId=1330183904096530718, language=CN, stringName=齐晓丹, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=河北医科大学药学院药剂教研室,河北 石家庄 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183903500939536, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, xref=null, ext=[AuthorCompanyExt(id=1330183903509328145, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, companyId=1330183903500939536, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Pharmacy Dept., School of Pharmacy, Hebei Medical University, Shijiazhuang 050017), AuthorCompanyExt(id=1330183903517716754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183902800490765, companyId=1330183903500939536, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河北医科大学药学院药剂教研室,河北 石家庄 050017)])])]
郭美瑜, 王璐, 齐晓丹*
作者信息
  • 河北医科大学药学院药剂教研室,河北 石家庄 050017
通讯作者:
齐晓丹(1975—),女,副教授,从事药物制剂新剂型、新技术的研究与开发。E-mail:
作者简介:

郭美瑜(1999—),女,硕士研究生,专业方向:药物新剂型与新技术。

Advances in Red Blood Cells as Drug Delivery Systems
Meiyu GUO, Lu WANG, Xiaodan QI*
Affiliations
  • Pharmacy Dept., School of Pharmacy, Hebei Medical University, Shijiazhuang 050017
出版时间: 2023-04-10 doi: 10.16522/j.cnki.cjph.2023.04.004
文章导航
收藏切换

传统的治疗药物存在稳定性差、摄取效率低、细胞毒性大以及靶向能力差等缺点。因此需要安全的药物传递系统来延长药物在体内的循环和暴露。以红细胞为载体的新型药物递送系统凭借其良好的生物相容性、低免疫原性以及长循环时间而逐渐成为理想的药物递送平台。基于红细胞的药物递送系统包括多种类型,主要有红细胞膜包裹纳米颗粒载药系统和基因工程红细胞等。另外,对红细胞进行功能化修饰,可显著增强靶向性,进一步开发和扩大红细胞载药体系在多种疾病治疗中的应用。本研究介绍了以红细胞为载体的化学药物及疫苗的递送方法,重点讨论了仿生纳米红细胞药物递送系统及其对机体各部位的靶向性研究,并且总结了近年来基因工程红细胞策略的研究进展。

靶向性  /  基因工程红细胞  /  药物递送系统  /  仿生纳米药物递送系统

Traditional therapeutic drugs have many shortcomings, such as poor stability, low uptake efficiency, high cytotoxicity and poor targeting ability. Therefore, safe drug delivery systems are needed to prolong drug circulation and exposure in vivo. New drug delivery systems based on red blood cells have gradually become ideal platforms for drug delivery due to their good biocompatibility, low immunogenicity and long circulation time. There are various types of drug delivery systems based on red blood cells, such as red blood cell membrane-encapsulated nanoparticle drug delivery systems and genetically engineered red blood cells. In addition, the functional modification of red blood cells can significantly enhance the targeting of red blood cell-based drug delivery systems to further develop and expand their applications in the treatment of various diseases. This review introduces the delivery methods of chemical drugs and vaccines using red blood cell-based carriers, focuses on bionic nano drug delivery systems and their targeting properties to various body positions. And the research progress of genetically engineered red blood cell-based strategy in recent years is summarized.

targeting  /  genetically engineered red blood cell  /  drug delivery system  /  bionic nano drug delivery system
郭美瑜, 王璐, 齐晓丹. 红细胞作为药物递送系统的研究进展. 中国医药工业杂志, 2023 , 54 (4) : 496 -503 . DOI: 10.16522/j.cnki.cjph.2023.04.004
Meiyu GUO, Lu WANG, Xiaodan QI. Advances in Red Blood Cells as Drug Delivery Systems[J]. Chinese Journal of Pharmaceuticals, 2023 , 54 (4) : 496 -503 . DOI: 10.16522/j.cnki.cjph.2023.04.004

参考文献 引证文献
排序方式:
[1]
DENG X, ZHAO J, LIU K, et al. Stealth PEGylated chitosan polyelectrolyte complex nanoparticles as drug delivery carrier [J]. J Biomater Sci Polym Ed, 2021,32(11): 1387-1405.
[2]
ALMEIDA B, NAG O K, ROGERS K E, et al. Recent progress in bioconjugation strategies for liposome-mediated drug delivery [J]. Molecules, 2020, 25(23): 5672.
[3]
DANIYAL M, JIAN Y Q, XIAO F, et al. Development of a nanodrug-delivery system, camouflaged by erythrocytes membrane for the chemo/phototherapy of cancer [J]. Nanomedicine, 2020, 15(7): 691-709.
[4]
XIAO Y, GU Y, QIN L, et al. Injectable thermosensitive hydrogel-based drug delivery system for local cancer therapy[J]. Colloids Surf B, 2021, 200: 111581.
[5]
HARISA G I, IBRAHIM M F, ALANAZI F, et al. Engineering erythrocytes as a novel carrier for the targeted delivery of the anticancer drug paclitaxel [J]. Saudi Pharm J, 2014, 22(3): 223-230.
[6]
MENG W, HE C, HAO Y, et al. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source [J]. Drug Deliv, 2020, 27(1): 585-598.
[7]
SHARMA R, ZHAO H, AL-SALEEM F H, et al. Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor[J]. Mol Immunol, 2014, 57(2): 247-254.
[8]
FANG R H, JIANG Y, FANG J C, et al. Cell membrane-derived nanomaterials for biomedical applications [J]. Biomaterials, 2017, 128: 69-83.
[9]
WANG C, HUANG J, ZHANG Y, et al. Construction and evaluation of red blood cells-based drug delivery system for chemo-photothermal therapy [J]. Colloids Surf B, 2021,204: 111789.
[10]
ZHANG S Q, FU Q, ZHANG Y J, et al. Surface loading of nanoparticles on engineered or natural erythrocytes for prolonged circulation time: strategies and applications [J]. Acta Pharmacol Sin, 2021, 42(7): 1040-1054.
[11]
WANG Y, CHEN X, HE D, et al. Surface-modified nanoerythrocyte loading DOX for targeted liver cancer chemotherapy [J]. Mol Pharm, 2018, 15(12): 5728-5740.
[12]
ZELEPUKIN, YAREMENKO A V, SHIPUNOVA V O, et al. Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth [J]. Nanoscale,2019, 11(4): 1636-1646.
[13]
WANG F, ZONG R, CHEN G. Erythrocyte-enabled immunomodulation for vaccine delivery [J]. J Control Release, 2022, 341: 314-328.
[14]
RANI N, ALZUBAIDI Z M, AZHARI H, et al. Novel engineering: biomimicking erythrocyte as a revolutionary platform for drugs and vaccines delivery [J]. Eur J Pharm,2021, 900: 174009.
[15]
HE H, YE J, WANG Y, et al. Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application [J]. J Control Release, 2014,176: 123-132.
[16]
ZHANG X, QIU M, GUO P, et al. Autologous red blood cell delivery of betamethasone phosphate sodium for long anti-inflammation [J]. Pharmaceutics, 2018, 10(4): 286.
[17]
CHENG Z, LIU S, WU X, et al. Autologous erythrocytes delivery of berberine hydrochloride with long-acting effect for hypolipidemia treatment [J]. Drug Delive, 2020, 27(1):283-291.
[18]
XU E, WU X, ZHANG X, et al. Study on the protection of dextran on erythrocytes during drug loading [J]. Colloids Surf B, 2020, 189: 110882.
[19]
CHEN Z, WU S, CHEN P, et al. Critical features for mesoporous silica nanoparticles encapsulated into erythrocytes [J]. ACS Appl Mater Inter, 2019, 11(5): 4790-4798.
[20]
ZAITSEV S, SPITZER D, MURCIANO J, et al. Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis [J]. J Pharmacol Exp Ther, 2010, 332(3): 1022-1031.
[21]
LORENTZ K M, KONTOS S, DIACERI G, et al. Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase [J]. Sci Adv, 2015, 1(6):e1500112.
[22]
陈萌,刘梦阳,张琦,等.红细胞膜药物递送系统的研究进展与反思[J].沈阳药科大学学报,2020,37(6):556-563.
[23]
YEW N S, DUFOUR E, PRZYBYLSKA M, et al. Erythrocytes encapsulated with phenylalanine hydroxylase exhibit improved pharmacokinetics and lowered plasma phenylalanine levels in normal mice [J]. Mol Genet Metab,2013, 109(4): 339-344.
[24]
冯之资,沈诗洋,莫然.基于红细胞的仿生载体用于光热剂递送和肿瘤光热治疗的研究进展[J].中国医药工业杂志,2022,53(1):28-36.
[25]
PAN D C, MYERSON J W, BRENNER J S, et al. Nanoparticle properties modulate their attachment and effect on carrier red blood cells [J]. Sci Rep UK, 2018, 8(1):1615.
[26]
LI H, JIN K, LUO M, et al. Size dependency of circulation and biodistribution of biomimetic nanoparticles: red blood cell membrane-coated nanoparticles [J]. Cells Basel, 2019,8(8): 881.
[27]
LIU J, ZHANG D, FANG G, et al. Erythrocyte membrane bioinspired near-infrared persistent luminescence nanocarriers for in vivo long-circulating bioimaging and drug delivery [J]. Biomaterials, 2018, 165: 39-47.
[28]
UKIDVE A, ZHAO Z, FEHNEL A, et al. Erythrocyte-driven immunization via biomimicry of their natural antigen-presenting function [J]. Proc Natl Acad Sci USA, 2020,117(30): 17727-17736.
[29]
HAN X, SHEN S, FAN Q, et al. Red blood cell-derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy [J]. Sci Adv, 2019, 5(10): w6870.
[30]
BANZ A, CREMEL M, REMBERT A, et al. In situ targeting of dendritic cells by antigen-loaded red blood cells:a novel approach to cancer immunotherapy [J]. Vaccine,2010, 28(17): 2965-2972.
[31]
XIA Q, ZHANG Y, LI Z, et al. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application [J]. Acta Pharm Sin B, 2019, 9(4):675-689.
[32]
WANG M, YAN W, CHU M, et al. Erythrocyte membrane-wrapped magnetic nanotherapeutic agents for reduction and removal of blood Cr(Ⅳ) [J]. ACS Appl Mater Interfaces,2020, 12(25): 28014-28023.
[33]
CHU J, SHAO C, HA S, et al. One-pot peptide cyclisation and surface modification of photosensitiser-loaded red blood cells for targeted photodynamic therapy [J]. Biomater Sci,2021, 9(23): 7832-7837.
[34]
FANG R H, HU C J, CHEN K N H, et al. Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles [J]. Nanoscale, 2013, 5(19): 8884.
[35]
JIANG Q, LIU Y, GUO R, et al. Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors [J]. Biomaterials,2019, 192: 292-308.
[36]
CHEN Z, WANG W, LI Y, et al. Folic acid-modified erythrocyte membrane loading dual drug for targeted and chemo-photothermal synergistic cancer therapy [J]. Mol Pharm, 2021, 18(1): 386-402.
[37]
HUANG J, LAI W, WANG Q, et al. Effective triple-negative breast cancer targeted treatment using iRGD-modified RBC membrane-camouflaged nanoparticles [J]. Int J Nanomed, 2021, 16: 7497-7515.
[38]
GUO Y, WANG D, SONG Q, et al. Erythrocyte membrane-enveloped polymeric nanoparticles as nanovaccine for induction of antitumor immunity against melanoma [J]. ACS Nano, 2015, 9(7): 6918-6933.
[39]
CHAI Z, RAN D, LU L, et al. Ligand-modified cell membrane enables the targeted delivery of drug nanocrystals to glioma [J]. ACS Nano, 2019, 13(5): 5591-5601.
[40]
DING Y, LV B, ZHENG J, et al. RBC-hitchhiking chitosan nanoparticles loading methylprednisolone for lung-targeting delivery [J]. J Control Release, 2022, 341: 702-715.
[41]
ANSELMO A C, KUMAR S, GUPTA V, et al. Exploiting shape, cellular-hitchhiking and antibodies to target nanoparticles to lung endothelium: synergy between physical, chemical and biological approaches [J]. Biomaterials,2015, 68: 1-8.
[42]
ZHENG J, LU C, DING Y, et al. Red blood cell-hitchhiking mediated pulmonary delivery of ivermectin: effects of nanoparticle properties [J]. Int J Pharm, 2022, 619:121719.
[43]
GUO J, AGOLA J O, SERDA R, et al. Biomimetic rebuilding of multifunctional red blood cells: modular design using functional components [J]. ACS Nano, 2020, 14(7):7847-7859.
[44]
WU P, JIANG X, YIN S, et al. Biomimetic recombinant of red blood cell membranes for improved photothermal therapy[J]. J Nanobiotechnol, 2021, 19(1): 213.
[45]
DEHNIAI D, WEI X, FANG R H, et al. Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization [J]. Adv Mater, 2017, 29(16): 1606209.
[46]
YAO Q, YANG G, WANG H, et al. Aging erythrocyte membranes as biomimetic nanometer carriers of liver-targeting chromium poisoning treatment [J]. Drug Deliv,2021, 28(1): 1455-1465.
[47]
WANG Y, ZHANG K, QIN X, et al. Biomimetic nanotherapies: red blood cell based core-shell structured nanocomplexes for atherosclerosis management [J]. Adv Sci, 2019, 6(12): 1900172.
[48]
CHAI Z, HU X, WEI X, et al. A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery[J]. J Control Release, 2017, 264: 102-111.
[49]
GAO C, WANG Y, SUN J, et al. Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer’s disease mice [J]. Acta Biomater, 2020, 108: 285-299.
[50]
IIU X, ZHANG L, JIANG W, et al. In vitro and in vivo evaluation of liposomes modified with polypeptides and red cell membrane as a novel drug delivery system for myocardium targeting [J]. Drug Deliv, 2020, 27(1): 599-606.
[51]
BRENNER J S, PAN D C, MYERSON J W, et al. Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude [J]. Nat Commun,2018, 9(1): 2684.
[52]
ZHAO Z, UKIDVE A, KRISHNAN V, et al. Systemic tumour suppression via the preferential accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung metastases [J]. Nat Biomed Eng, 2021, 5(5): 441-454.
[53]
ZHOU P, OUCHARI M, XUE Y, et al. In vitro generation of red blood cells from stem cell and targeted therapy [J]. Cell Transplant, 2020, 29: 1504.
[54]
BAX B E. Erythrocytes as carriers of therapeutic enzymes[J]. Pharmaceutics, 2020, 12(5): 435.
[55]
MCARDEL S L, DUGAST A, HOOVER M E, et al. Anti-tumor effects of RTX-240: an engineered red blood cell expressing 4-1BB ligand and interleukin-15 [J]. Cancer Immunol, 2021, 70(9): 2701-2719.
[56]
HUANG N J, PISHESHA N, MUKHERJEE J, et al. Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin [J]. Nat Commun, 2017, 8(1): 423.
[57]
GAO L, WANG H, NAN L, et al. Erythrocyte membrane-wrapped pH sensitive polymeric nanoparticles for non-small cell lung cancer therapy [J]. Bioconjug Chem, 2017,28(10): 2591-2598.
[58]
LI N, CAI H, JIANG L, et al. Enzyme-sensitive and amphiphilic PEGylated dendrimer-paclitaxel prodrug-based nanoparticles for enhanced stability and anticancer efficacy[J]. ACS Appl Mater Interfaces, 2017, 9(8): 6865-6877.
[59]
DENG X, CHEN Y, CHENG Z, et al. Rational design of a comprehensive cancer therapy platform using temperature-sensitive polymer grafted hollow gold nanospheres:simultaneous chemo/photothermal/photodynamic therapy triggered by a 650 nm laser with enhanced anti-tumor efficacy [J]. Nanoscale, 2016, 8(12): 6837-6850.
[60]
WANG L, CHEN S, PEI W, et al. Magnetically targeted erythrocyte membrane coated nanosystem for synergistic photothermal/chemotherapy of cancer [J]. J Mater Chem B,2020, 8(18): 4132-4142.
2023年第54卷第4期
19
2
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2023.04.004
  • 接收时间:2022-05-30
  • 首发时间:2026-11-19
  • 出版时间:2023-04-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-05-30
基金
作者信息
    河北医科大学药学院药剂教研室,河北 石家庄 050017

通讯作者:

齐晓丹(1975—),女,副教授,从事药物制剂新剂型、新技术的研究与开发。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.04.004
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏